Study of Catatonic Syndrome in Adults at Basurto Hospital Examining Incidence, Comorbidities, and Short-Term Outcomes

What this Trial Is About

Researchers are studying catatonic syndrome, a serious neuropsychiatric condition with motor, behavioral, and speech symptoms, in adults treated at Basurto University Hospital in Spain. The study aims to understand how often catatonia occurs, its patient characteristics, treatment responses, and short-term outcomes. This observational study will include all adult patients diagnosed with catatonia of any cause from January 2024 to December 2025, examining a broad hospital population across different clinical settings. The study does not involve experimental treatments but will collect detailed clinical data from patients diagnosed according to DSM-5 criteria. Severity and subtype of catatonia will be assessed using the Bush-Francis Catatonia Rating Scale, with patients followed through their hospital stay until discharge. Researchers will document treatments given during routine care, including benzodiazepines and other interventions, and monitor patients clinical progress and complications. Participants will have their demographic data, clinical features, underlying diagnoses, treatment responses, and hospital outcomes recorded. Data collection includes clinical assessments, rating scales, and tracking of hospital events such as complications and length of stay. The primary outcome is the annual incidence of catatonia in the hospital population. The study will also analyze secondary variables such as symptom severity, treatment effects, and short-term recovery patterns. Participation involves no extra procedures beyond standard care, and consent procedures accommodate acute illness situations.

Catatonic Syndrome in Adult Patients at Basurto Hospital: A Descriptive Study of Incidence, Comorbidity, and Short-Term Outcomes